RIKEN CDB RIKEN CDB true 独立行政法人　理化学研究所 条件を付加する。<br>(1) 当該マウスを用いる論文発表に際しては Acc. No. CDB0020K とともに当該マウスを記載すること。（Acc. No. についてはホームページ(http://www2.clst.riken.jp/arg/mutant%20mice%20list.html) を参照） (2) 当該マウスを用いる論文発表に際しては　その由来として第一報論文 The Journal of Neuroscience, 25, 5097-5108 (2005). を引用すること。(3) 発表論文を樹立者(mutant.bdr@riken.jp)に連絡すること。 P1 phage Cre, P1 phage loxP site, mouse Emx2 genomic DNA (1) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the Accession No. CDB0020K and the BIOLOGICAL RESOURCE is requested (http://www2.clst.riken.jp/arg/mutant%20mice%20list.html). (2) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the literature designed by the DEPOSITOR is requested, The Journal of Neuroscience, 25, 5097-5108 (2005). (3) Please inform the DEVELOPER (mutant.bdr@riken.jp) about the paper when published. RIKEN RBRC02272 TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] <a href='https://brc.riken.jp/mus/pcr02272'>Genotyping protocol -PCR-</a> Cre/loxP system Neurobiology Research B6.Cg-Emx2<tm2(cre)Sia>/SiaRbrc Emx2(Cre) (Acc. No. CDB0020K) Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> C (3-6 months) C（3〜6か月） Emx2(Cre) (Acc. No. CDB0020K) Emx2(Cre) (Acc. No. CDB0020K)